KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 77 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,736 | -24.9% | 22,191 | +0.4% | 0.00% | – |
| Q2 2023 | $39,572 | -40.2% | 22,107 | +29.9% | 0.00% | – |
| Q1 2023 | $66,212 | +16.4% | 17,021 | +1.7% | 0.00% | – |
| Q4 2022 | $56,882 | -31.5% | 16,730 | +10.7% | 0.00% | – |
| Q3 2022 | $83,000 | +25.8% | 15,111 | +2.5% | 0.00% | – |
| Q2 2022 | $66,000 | -58.2% | 14,744 | -30.8% | 0.00% | – |
| Q1 2022 | $158,000 | -7.1% | 21,299 | -19.2% | 0.00% | – |
| Q4 2021 | $170,000 | +14.9% | 26,371 | +4.0% | 0.00% | – |
| Q3 2021 | $148,000 | -55.4% | 25,345 | -21.2% | 0.00% | -100.0% |
| Q2 2021 | $332,000 | +7.8% | 32,172 | +9.9% | 0.00% | 0.0% |
| Q1 2021 | $308,000 | -26.0% | 29,268 | +8.8% | 0.00% | -50.0% |
| Q4 2020 | $416,000 | +39.6% | 26,889 | +31.6% | 0.00% | +100.0% |
| Q3 2020 | $298,000 | -25.9% | 20,433 | -3.7% | 0.00% | -50.0% |
| Q2 2020 | $402,000 | +72.5% | 21,220 | +75.0% | 0.00% | 0.0% |
| Q1 2020 | $233,000 | -43.9% | 12,127 | -44.0% | 0.00% | 0.0% |
| Q4 2019 | $415,000 | +83.6% | 21,664 | -7.6% | 0.00% | +100.0% |
| Q3 2019 | $226,000 | +63.8% | 23,455 | +2.1% | 0.00% | 0.0% |
| Q2 2019 | $138,000 | -9.2% | 22,962 | -11.7% | 0.00% | 0.0% |
| Q1 2019 | $152,000 | -36.9% | 26,015 | +1.3% | 0.00% | -50.0% |
| Q4 2018 | $241,000 | -53.8% | 25,675 | -16.2% | 0.00% | -50.0% |
| Q3 2018 | $522,000 | -3.3% | 30,630 | -3.6% | 0.00% | 0.0% |
| Q2 2018 | $540,000 | +46.7% | 31,759 | +15.7% | 0.00% | +100.0% |
| Q1 2018 | $368,000 | +26.0% | 27,442 | -9.8% | 0.00% | 0.0% |
| Q4 2017 | $292,000 | -7.9% | 30,437 | +5.4% | 0.00% | -33.3% |
| Q3 2017 | $317,000 | +28.9% | 28,871 | +6.3% | 0.00% | +50.0% |
| Q2 2017 | $246,000 | -23.8% | 27,154 | +8.0% | 0.00% | -33.3% |
| Q1 2017 | $323,000 | +8.8% | 25,133 | -20.5% | 0.00% | 0.0% |
| Q4 2016 | $297,000 | +21.7% | 31,601 | +26.2% | 0.00% | 0.0% |
| Q3 2016 | $244,000 | +22.6% | 25,032 | -15.6% | 0.00% | 0.0% |
| Q2 2016 | $199,000 | -23.8% | 29,655 | +1.3% | 0.00% | -25.0% |
| Q1 2016 | $261,000 | -38.6% | 29,279 | -8.8% | 0.00% | -20.0% |
| Q4 2015 | $425,000 | +37.1% | 32,097 | +9.0% | 0.01% | +25.0% |
| Q3 2015 | $310,000 | -63.7% | 29,441 | -6.3% | 0.00% | -66.7% |
| Q2 2015 | $855,000 | -11.6% | 31,434 | -0.5% | 0.01% | +9.1% |
| Q1 2015 | $967,000 | +5.1% | 31,580 | +28.5% | 0.01% | 0.0% |
| Q4 2014 | $920,000 | +227.4% | 24,569 | +307.2% | 0.01% | +175.0% |
| Q2 2014 | $281,000 | +15.2% | 6,034 | -23.7% | 0.00% | +33.3% |
| Q1 2014 | $244,000 | – | 7,913 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |